Viewing Study NCT01136161


Ignite Creation Date: 2025-12-24 @ 12:06 PM
Ignite Modification Date: 2026-01-17 @ 9:40 AM
Study NCT ID: NCT01136161
Status: COMPLETED
Last Update Posted: 2013-01-24
First Post: 2010-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTIĀ® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
Sponsor: Archivel Farma S.L.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Latent Tuberculosis Infection View
None Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LTBI (Latent Tuberculosis Infection) View
None TB (Tuberculosis) View
None Vaccine View